The Efficacy and Safety of Intra-Arterial Administration of Rexmyelocel T to treat Critical Limb Ischemia in Subjects with Diabetes Mellitus: Two Pivotal, Placebo Controlled, Double-Blind, Parallel-Group, Adaptive Trials Eficacia y seguridad en la administración intraarterial de Rexmyelocel-T en el tratamiento de la isquemia crítica de extremidades inferiores en pacientes con diabetes mellitus: dos ensayos pivotales, adaptativos, controlados con placebo, doble ciego y con grupos paralelos.

Trial Profile

The Efficacy and Safety of Intra-Arterial Administration of Rexmyelocel T to treat Critical Limb Ischemia in Subjects with Diabetes Mellitus: Two Pivotal, Placebo Controlled, Double-Blind, Parallel-Group, Adaptive Trials Eficacia y seguridad en la administración intraarterial de Rexmyelocel-T en el tratamiento de la isquemia crítica de extremidades inferiores en pacientes con diabetes mellitus: dos ensayos pivotales, adaptativos, controlados con placebo, doble ciego y con grupos paralelos.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 26 May 2017

At a glance

  • Drugs Rexmyelocel T (Primary)
  • Indications Peripheral ischaemia
  • Focus Therapeutic Use
  • Sponsors Rexgenero
  • Most Recent Events

    • 05 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top